Cargando…
Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802166/ https://www.ncbi.nlm.nih.gov/pubmed/35114173 http://dx.doi.org/10.1016/j.amjmed.2021.12.019 |
_version_ | 1784642620219195392 |
---|---|
author | Berges, Maja Foster, Keith Foster, Jennifer Martinez, Lisa Martinez, Sean Fiedler, Benjamin DeMets, David L. Maki, Dennis G. Hennekens, Charles H. |
author_facet | Berges, Maja Foster, Keith Foster, Jennifer Martinez, Lisa Martinez, Sean Fiedler, Benjamin DeMets, David L. Maki, Dennis G. Hennekens, Charles H. |
author_sort | Berges, Maja |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8802166 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88021662022-01-31 Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations Berges, Maja Foster, Keith Foster, Jennifer Martinez, Lisa Martinez, Sean Fiedler, Benjamin DeMets, David L. Maki, Dennis G. Hennekens, Charles H. Am J Med Commentary Elsevier Inc. 2022-05 2022-01-31 /pmc/articles/PMC8802166/ /pubmed/35114173 http://dx.doi.org/10.1016/j.amjmed.2021.12.019 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Berges, Maja Foster, Keith Foster, Jennifer Martinez, Lisa Martinez, Sean Fiedler, Benjamin DeMets, David L. Maki, Dennis G. Hennekens, Charles H. Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations |
title | Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations |
title_full | Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations |
title_fullStr | Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations |
title_full_unstemmed | Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations |
title_short | Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations |
title_sort | updates for health providers on monoclonal antibodies for covid-19: less promising adjunct and never an alternative to vaccinations |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802166/ https://www.ncbi.nlm.nih.gov/pubmed/35114173 http://dx.doi.org/10.1016/j.amjmed.2021.12.019 |
work_keys_str_mv | AT bergesmaja updatesforhealthprovidersonmonoclonalantibodiesforcovid19lesspromisingadjunctandneveranalternativetovaccinations AT fosterkeith updatesforhealthprovidersonmonoclonalantibodiesforcovid19lesspromisingadjunctandneveranalternativetovaccinations AT fosterjennifer updatesforhealthprovidersonmonoclonalantibodiesforcovid19lesspromisingadjunctandneveranalternativetovaccinations AT martinezlisa updatesforhealthprovidersonmonoclonalantibodiesforcovid19lesspromisingadjunctandneveranalternativetovaccinations AT martinezsean updatesforhealthprovidersonmonoclonalantibodiesforcovid19lesspromisingadjunctandneveranalternativetovaccinations AT fiedlerbenjamin updatesforhealthprovidersonmonoclonalantibodiesforcovid19lesspromisingadjunctandneveranalternativetovaccinations AT demetsdavidl updatesforhealthprovidersonmonoclonalantibodiesforcovid19lesspromisingadjunctandneveranalternativetovaccinations AT makidennisg updatesforhealthprovidersonmonoclonalantibodiesforcovid19lesspromisingadjunctandneveranalternativetovaccinations AT hennekenscharlesh updatesforhealthprovidersonmonoclonalantibodiesforcovid19lesspromisingadjunctandneveranalternativetovaccinations |